Prostaglandin E2 treatment of impotence

Details Prostaglandin E2 treatment of impotence Prostaglandin E2 treatment of impotence

1993-07-12

1998-01-13

Jarvis, William R. A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 31557

Patent

active

057080313

ABSTRACT:
Disclosed are compositions and methods for the treatment of male impotence, wherein erectile dysfunction is alleviated by administering a pharmaceutically acceptable formulation containing prostaglandin PGE.sub.2. An antidote for the effects of administration of the PGE.sub.2, or for treating priapism of other etiology, is also disclosed.

REFERENCES:
patent: 4311707 (1982-01-01), Birnbaum et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4955878 (1990-09-01), See et al.
Schramek et al, Derwent Drug File Abstracts, vol. 90, abstract No. 01345, 1989.
"Impotence," Medical Aspects of Human Sexuality, pp. 66-68, May 1991.
Gauger, Laura J. and Curet, Louis B., "Comparative Efficacy of Intravaginal Prostaglandin E-2 in the Gel and Suppository Forms for Cervical Ripening,"DICP, The Annals of Pharmacotherapy,25:456-460,May 91.
Cavallini, Giorgio, "Minoxidil vs. Nitroglycerine: A Perspective Double Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence,"The Journal of Urology, 146:50-53. Jul. 1991.
Artoux, Michelle J., "Alprostadil in Impotence,"DICP, The Annals of Pharmacotherapy, 25:363-365, Apr. 1991.
Burnakis, Thomas G., "Amyl Nitrite for the Treatment of Penile Tumescence," Hospital Pharmacy, 26:343-344, Apr. 1991.
Physicians' Desk Reference, 45th ed., pp. 627-628, 1991.
Lehninger, Albert L., Biochemistry, 2nd ed., 1975.
Ganong, William F., Review of Medical Physiology, 7th ed., pp. 187, 226, 1975.
Physicians' Desk Reference, 45th ed., pp. 2250-2251, 1991.
Catanzarite, Valerian A. and Aisenbrey, Gary, "Prostaglandins: Mundane and Visionary Applications," Contemporary OB/Gyn, pp. 21-41, Oct. 1987.
"Agents for Patent Ductus Arteriosus," Facts & Comparisons, pp. 732-732a, Nov. 1989.
"Prostin E-2," package insert of the Upjohn Company, revised Oct. 1990.
"Hemabat," package insert of the Upjohn Company, Nov. 1989.

Affiliated with

Also associated with

Rating

Prostaglandin E2 treatment of impotence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostaglandin E2 treatment of impotence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin E2 treatment of impotence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-326781